Modulation of GPCR conformations by ligands, G-proteins, and arrestins

被引:2
|
作者
Prossnitz, E. R. [1 ]
Sklar, L. A. [1 ]
机构
[1] Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1007/2789_2006_010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G-protein-coupled receptors (GPCRs) have traditionally been thought to adopt two conformations: the inactive unliganded conformation and the active ligand-bound conformation. Interactions with G-proteins in cells and membranes are known to modulate the affinity of the receptor for ligand and therefore the conformation of the receptor. Such observations led to the proposal of the ternary complex model. However, subsequent studies of constitutively active GPCRs led to the development of an extended version of this model to account for active conformations of the receptor in the absence of agonist. A significant difficulty with many of the studies, upon which this latter model was based, is the lack of knowledge of receptor and G-protein concentrations due to the two-dimensional nature of the membranes used to perform the measurements. Over the past decade, we have studied the interaction of GPCRs, G-proteins, arrestins, and ligands in solubilized systems, where the concentration of each component can be defined. Here we summarize results of these studies as they pertain to the regulation of GPCR conformations and affinities for interacting species.
引用
收藏
页码:211 / 228
页数:18
相关论文
共 50 条
  • [1] An Insight into GPCR and G-Proteins as Cancer Drivers
    Chaudhary, Preeti Kumari
    Kim, Soochong
    [J]. CELLS, 2021, 10 (12)
  • [2] β-arrestins and heterotrimeric G-proteins:: collaborators and competitors in signal transduction
    Defea, K.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 : S298 - S309
  • [3] Modulation of receptors and G-proteins
    Angeli, P
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2004, 13 (1-2) : 34 - 37
  • [4] Modulation of Recptors and G-Proteins
    Piero Angeli
    [J]. Medicinal Chemistry Research, 2004, 13 : 34 - 37
  • [5] Using solution NMR to explore how ligands, G proteins, and arrestins allosterically modulate GPCR conformational dynamics
    Ziarek, Joshua
    Bumbak, Fabian
    Robson, Scott
    [J]. BIOPHYSICAL JOURNAL, 2022, 121 (03) : 429A - 429A
  • [6] Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology
    Rahman, Md. Mominur
    Mim, Sadia Afsana
    Islam, Md. Rezaul
    Sultana, Nasrin
    Ahmed, Muniruddin
    Kamal, Mohammad Amjad
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (01) : 2 - 5
  • [7] Asymmetric conformational changes in a GPCR dimer controlled by G-proteins
    Damian, Marjorie
    Martin, Aimee
    Mesnier, Danielle
    Pin, Jean-Philippe
    Baneres, Jean-Louis
    [J]. EMBO JOURNAL, 2006, 25 (24): : 5693 - 5702
  • [8] MODULATION OF A KCA CHANNEL BY CALCIUM AND G-PROTEINS
    VACA, LA
    SCHILLING, WP
    KUNZE, DL
    [J]. FASEB JOURNAL, 1992, 6 (01): : A383 - A383
  • [9] G-PROTEINS AND MODULATION OF INSULIN-SECRETION
    ROBERTSON, RP
    SEAQUIST, ER
    WALSETH, TF
    [J]. DIABETES, 1991, 40 (01) : 1 - 6
  • [10] Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2
    Malfacini, D.
    Ambrosio, C.
    Gro', M. C.
    Sbraccia, M.
    Trapella, C.
    Guerrini, R.
    Bonora, M.
    Pinton, P.
    Costa, T.
    Calo, G.
    [J]. PLOS ONE, 2015, 10 (08):